• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Rahul Wadke

Mumbai, March 13 Emco Ltd’s upcoming 540-MW merchant power plant in Maharashtra plans to implement a hybrid model for selling power.

Of the total power produced, 50 per cent would be sold on a short-term basis to big industrial consumers and the rest to State electricity utilities on long-term basis.

Financial closure for the first phase of 270 MW of the project has already been achieved. A consortium led by Axis Bank is funding Rs 1,000 crore and the company from its internal accruals is investing Rs 240 crore, said Mr Rajesh Jain, Chairman and Managing Director.

He said that the company could get an average price of Rs 4 per unit from electricity sale. From long-term agreement of 25 years, Emco could get a price of Rs 2.60-2.80 per unit and up to Rs 4 for short-term arrangement of five years, Mr Jain said.

The plant will come up at Warora in Chandrapur district. Land acquisition, environmental clearances and fuel supply agreement is already in place.

The coal would be sourced from coalmines in Chhattisgarh and water from the Warora river.

Mr Jain said that unlike the conventional thermal plant, the Warora plant would not have a pond to hold fly ash.

It would be directly supplied to a number of cement plants, which are located in the area, he said.

The plant would be operational from 2010 and critical equipment such as boilers, turbines and generators are being sourced from Chinese manufacturers.

The balance of plant engineering is being handled in-house.

More Stories on : Business Models | Power

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
US co Aptuit unveils tool for accelerating drug discovery, cutting costs

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line